Amy H. Kim

Statistics

Publications

Citations

212

H-Index

Active since

2001

Affiliations

National Institute of Environmental Health Sciences(Current)

Amy H. Kim is an author at National Institute of Environmental Health Sciences specializing in medicine, physiology, and immunotherapy for solid tumors.

Publications per year

2001–2014

Publications

A Phase Ib study evaluating MNRP1685A, a fully human anti-NRP1 monoclonal antibody, in combination with bevacizumab and paclitaxel in patients with advanced solid tumors

Amita Patnaik, Patricia LoRusso, Wells A. Messersmith et al. · Cancer Chemotherapy and Pharmacology · 2014 · 80 citations

Medicine, Oncology, Cancer Pharmacology +12

Induction of Hepatic 8-Oxo-deoxyguanosine Adducts by 2,3,7,8-Tetrachlorodibenzo-<i>p</i>-dioxin in Sprague−Dawley Rats Is Female-Specific and Estrogen-Dependent

Michael E. Wyde, Victoria Wong, Amy H. Kim et al. · Chemical Research in Toxicology · 2001 · 50 citations

Medicine, Endocrinology, Toxicology +15

Temporal Trends of Cardiac and Respiratory Responses to Ventilatory Challenges in Congenital Central Hypoventilation Syndrome

Paul M. Macey, Claire Valderama, Amy H. Kim et al. · Pediatric Research · 2004 · 39 citations · Full text

Medicine, Pediatrics, Physiology +17

Physiological modeling of a proposed mechanism of enzyme induction by TCDD

Michael C. Kohn, Nigel J. Walker, Amy H. Kim et al. · Toxicology · 2001 · 27 citations

Life Sciences, Biochemistry, Physiology +14

Impact of Physiologically Based Pharmacokinetic Modeling on Benchmark Dose Calculations for TCDD-Induced Biochemical Responses

Amy H. Kim, Michael C. Kohn, Christopher J. Portier et al. · Regulatory Toxicology and Pharmacology · 2002 · 16 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

1–5 of 5